Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Liabilities and Shareholders Equity (2020 - 2026)

Privia Health has reported Liabilities and Shareholders Equity over the past 6 years, most recently at $1.4 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 20.57% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $5.2 billion, up 17.9%, while the annual FY2025 figure was $1.4 billion, 20.57% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $1.4 billion at Privia Health, up from $1.4 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $1.4 billion in Q4 2025 and troughed at $348.3 million in Q1 2021.
  • A 5-year average of $935.2 million and a median of $965.0 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 108.64% in 2021 and later increased 13.59% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $686.4 million in 2021, then grew by 15.51% to $792.8 million in 2022, then rose by 26.12% to $999.9 million in 2023, then increased by 13.59% to $1.1 billion in 2024, then rose by 20.57% to $1.4 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for PRVA at $1.4 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.3 billion in Q2 2025.